Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis

CA Wallace, EH Giannini, SJ Spalding… - Arthritis & …, 2012 - Wiley Online Library
Objective To determine whether aggressive treatment initiated early in the course of rheumatoid
factor (RF)–positive or RF‐negative polyarticular juvenile idiopathic arthritis (JIA) can …

Rilonacept for colchicine-resistant or-intolerant familial Mediterranean fever: a randomized trial

PJ Hashkes, SJ Spalding, EH Giannini… - Annals of internal …, 2012 - acpjournals.org
Chinese translation This article has been corrected. The original version (PDF) is appended
to this article as a Supplement . Background: Currently, there is no proven alternative …

The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma …

…, DA Kietz, P Rosen, SJ Spalding… - The Journal of …, 2009 - jrheum.org
Objective. To develop and evaluate a Localized Scleroderma (LS) Skin Severity Index (LoSSI)
and global assessments’ clinimetric property and effect on quality of life (QOL). Methods. …

Randomized, double‐blind, placebo‐controlled trial of the efficacy and safety of rilonacept in the treatment of systemic juvenile idiopathic arthritis

…, D Milojevic, JW Verbsky, SJ Spalding… - Arthritis & …, 2014 - Wiley Online Library
Objective To assess the efficacy and safety of rilonacept, an interleukin‐1 inhibitor, in a
randomized, double‐blind, placebo‐controlled trial. Methods An initial 4‐week double‐blind …

Comparing presenting clinical features in 48 children with microscopic polyangiitis to 183 children who have granulomatosis with polyangiitis (Wegener's): an …

…, K Nanda, DM Wahezi, SJ Spalding… - Arthritis & …, 2016 - Wiley Online Library
Objective To uniquely classify children with microscopic polyangiitis (MPA), to describe their
demographic characteristics, presenting clinical features, and initial treatments in …

[HTML][HTML] Three-dimensional and thermal surface imaging produces reliable measures of joint shape and temperature: a potential tool for quantifying arthritis

SJ Spalding, CK Kwoh, R Boudreau, J Enama… - Arthritis research & …, 2008 - Springer
Introduction The assessment of joints with active arthritis is a core component of widely used
outcome measures. However, substantial variability exists within and across examiners in …

Clinically inactive disease in a cohort of children with new-onset polyarticular juvenile idiopathic arthritis treated with early aggressive therapy: time to achievement …

CA Wallace, EH Giannini, SJ Spalding… - The Journal of …, 2014 - jrheum.org
Objective. To determine the elapsed time while receiving aggressive therapy to the first
observation of clinically inactive disease (CID), total duration of CID and potential predictors of …

[HTML][HTML] Takayasu arteritis in the pediatric population: a contemporary United States-based single center cohort

HS Szugye, AS Zeft, SJ Spalding - Pediatric Rheumatology, 2014 - Springer
Background Takayasu Arteritis is an idiopathic, chronic, large vessel vasculitis involving the
aorta and its primary branches. Few studies have been done in pediatric patients to date …

Childhood-onset eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): a contemporary single-center cohort

S Gendelman, A Zeft, SJ Spalding - The Journal of rheumatology, 2013 - jrheum.org
Objective. To date only 38 cases of childhood-onset eosinophilic granulomatosis with
polyangiitis (cEGPA; formerly Churg-Strauss syndrome) have been reported. Additional patients …

Serum S100A8/A9 and S100A12 levels in children with polyarticular forms of juvenile idiopathic arthritis: relationship to maintenance of clinically inactive disease …

…, D Foell, AL Johnson, SJ Spalding… - Arthritis & …, 2019 - Wiley Online Library
Objective To determine the relationship between serum levels of S100A8/A9 and S100A12
and the maintenance of clinically inactive disease during anti–tumor necrosis factor (anti‐ …